HUP9900323A2 - Bakteriofág endoszialidáz aktivitással rendelkező rekombináns fehérje - Google Patents
Bakteriofág endoszialidáz aktivitással rendelkező rekombináns fehérjeInfo
- Publication number
- HUP9900323A2 HUP9900323A2 HU9900323A HUP9900323A HUP9900323A2 HU P9900323 A2 HUP9900323 A2 HU P9900323A2 HU 9900323 A HU9900323 A HU 9900323A HU P9900323 A HUP9900323 A HU P9900323A HU P9900323 A2 HUP9900323 A2 HU P9900323A2
- Authority
- HU
- Hungary
- Prior art keywords
- recombinant protein
- enzymatic activity
- bacteriophage
- bacteriophage endosialidase
- endosialidase enzymatic
- Prior art date
Links
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 108010014459 endo-N-acetylneuraminidase Proteins 0.000 title 1
- 230000002255 enzymatic effect Effects 0.000 title 1
- 241001515965 unidentified phage Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01129—Endo-alpha-sialidase (3.2.1.129)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9513683.4A GB9513683D0 (en) | 1995-07-05 | 1995-07-05 | Products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP9900323A2 true HUP9900323A2 (hu) | 1999-05-28 |
Family
ID=10777153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9900323A HUP9900323A2 (hu) | 1995-07-05 | 1996-07-01 | Bakteriofág endoszialidáz aktivitással rendelkező rekombináns fehérje |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6331425B1 (hu) |
| EP (1) | EP0842284A1 (hu) |
| JP (1) | JPH11509728A (hu) |
| KR (1) | KR19990028642A (hu) |
| CN (1) | CN1191572A (hu) |
| AU (1) | AU718184B2 (hu) |
| CA (1) | CA2226258A1 (hu) |
| CZ (1) | CZ421397A3 (hu) |
| GB (1) | GB9513683D0 (hu) |
| HU (1) | HUP9900323A2 (hu) |
| NO (1) | NO980021L (hu) |
| NZ (1) | NZ311738A (hu) |
| SK (1) | SK1398A3 (hu) |
| WO (1) | WO1997002351A1 (hu) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6399097B1 (en) | 1997-10-31 | 2002-06-04 | New Horizons Diagnostics Corporation | Composition for treatment of a bacterial infection of the digestive tract |
| US6752988B1 (en) | 2000-04-28 | 2004-06-22 | New Horizons Diagnostic Corp | Method of treating upper resiratory illnesses |
| US6056954A (en) | 1997-10-31 | 2000-05-02 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses |
| US6406692B1 (en) | 1997-10-31 | 2002-06-18 | New Horizons Diagnostics Corp | Composition for treatment of an ocular bacterial infection |
| US6423299B1 (en) | 1997-10-31 | 2002-07-23 | Vincent Fischetti | Composition for treatment of a bacterial infection of an upper respiratory tract |
| US6432444B1 (en) | 1997-10-31 | 2002-08-13 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymes for treating dermatological infections |
| US6428784B1 (en) | 1997-10-31 | 2002-08-06 | New Horizons Diagnostics Corp | Vaginal suppository for treating group B Streptococcus infection |
| US6399098B1 (en) | 1997-10-31 | 2002-06-04 | New Horizons Diagnostics Corp | Composition for treating dental caries caused by streptococcus mutans |
| US7232576B2 (en) | 1997-10-31 | 2007-06-19 | New Horizons Diagnostics Corp | Throat lozenge for the treatment of Streptococcus Group A |
| US6277399B1 (en) | 1997-10-31 | 2001-08-21 | New Horizon Diagnostics Corporation | Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections |
| DE19856283A1 (de) * | 1998-12-07 | 2000-06-08 | Bosch Gmbh Robert | Bedämpfungsschaltung für Zweidraht-Bussystem |
| US20020127215A1 (en) * | 1999-09-14 | 2002-09-12 | Lawrence Loomis | Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| US20020187136A1 (en) * | 2000-04-28 | 2002-12-12 | Lawrence Loomis | Use of bacterial phage associated lysing enzymes for treating various illnesses |
| US6395504B1 (en) | 2000-09-01 | 2002-05-28 | New Horizons Diagnostics Corp. | Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants |
| US8512710B2 (en) | 2002-11-22 | 2013-08-20 | Ansun Biopharma, Inc. | Class of therapeutic protein based molecules |
| US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| US7553822B2 (en) * | 2003-10-30 | 2009-06-30 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for inhibiting translation of a Mect1-MAML2 chimeric gene |
| US20050282155A1 (en) * | 2004-06-17 | 2005-12-22 | Lucigen Corporation | Viral libraries from uncultivated viruses and polypeptides produced therefrom |
| WO2015173812A1 (en) | 2014-05-12 | 2015-11-19 | Rappaport Family Institute For Research In The Medical Sciences | Compositions comprising il-31 and uses thereof |
| EP3072900A1 (en) | 2015-03-27 | 2016-09-28 | Medizinische Hochschule Hannover | Anti-tumour medicament based on adenovirus |
| CN106906236B (zh) * | 2017-04-10 | 2020-04-10 | 中国科学院深海科学与工程研究所 | 唾液酸酶基因重组表达载体及其构建方法，唾液酸酶及其制备方法 |
| US10174295B1 (en) | 2017-08-01 | 2019-01-08 | The Charles Stark Draper Laboratory, Inc. | Composition of matter: engineering of Escherichia coli phage K1E |
| CN112522236A (zh) * | 2020-12-23 | 2021-03-19 | 南京农业大学 | 一种针对k1荚膜大肠杆菌的噬菌体内切唾液酸酶及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4695541A (en) | 1985-01-31 | 1987-09-22 | Molecular Diagnostics, Inc. | Enzymatic detection of bacterial capsular polysaccharide antigens |
| US5654176A (en) * | 1987-05-28 | 1997-08-05 | Amrad Corporation Limited | Fusion proteins containing glutathione-s-transferase |
| NZ224663A (en) | 1987-05-28 | 1990-11-27 | Amrad Corp Ltd | Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors |
| GB9120221D0 (en) * | 1991-09-23 | 1991-11-06 | Smithkline Beecham Biolog | Novel compounds |
| GB9210337D0 (en) | 1992-05-14 | 1992-07-01 | Univ Court Of The University O | Feline leukaemia virus vaccine |
| IT1262981B (it) | 1992-09-09 | 1996-07-23 | Tecnogen Scpa | Procedimento per la purificazione della proteina big endotelina |
| WO1994025061A1 (en) * | 1993-04-23 | 1994-11-10 | Glyko, Inc. | Methods and compositions for treating diseases with carbohydrate modifying enzymes |
| US6303369B1 (en) | 1993-09-30 | 2001-10-16 | Carl Spana | Protein expression system |
-
1995
- 1995-07-05 GB GBGB9513683.4A patent/GB9513683D0/en active Pending
-
1996
- 1996-07-01 AU AU63116/96A patent/AU718184B2/en not_active Ceased
- 1996-07-01 CA CA002226258A patent/CA2226258A1/en not_active Abandoned
- 1996-07-01 CN CN96195235A patent/CN1191572A/zh active Pending
- 1996-07-01 HU HU9900323A patent/HUP9900323A2/hu unknown
- 1996-07-01 CZ CZ974213A patent/CZ421397A3/cs unknown
- 1996-07-01 JP JP9504915A patent/JPH11509728A/ja not_active Ceased
- 1996-07-01 US US08/983,275 patent/US6331425B1/en not_active Expired - Fee Related
- 1996-07-01 NZ NZ311738A patent/NZ311738A/en unknown
- 1996-07-01 EP EP96922129A patent/EP0842284A1/en not_active Withdrawn
- 1996-07-01 WO PCT/GB1996/001577 patent/WO1997002351A1/en not_active Application Discontinuation
- 1996-07-01 SK SK13-98A patent/SK1398A3/sk unknown
- 1996-07-01 KR KR1019970709964A patent/KR19990028642A/ko not_active Application Discontinuation
-
1998
- 1998-01-02 NO NO980021A patent/NO980021L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MX9800097A (es) | 1998-08-30 |
| CN1191572A (zh) | 1998-08-26 |
| EP0842284A1 (en) | 1998-05-20 |
| NZ311738A (en) | 2001-05-25 |
| KR19990028642A (ko) | 1999-04-15 |
| CZ421397A3 (cs) | 1998-04-15 |
| WO1997002351A1 (en) | 1997-01-23 |
| AU718184B2 (en) | 2000-04-06 |
| JPH11509728A (ja) | 1999-08-31 |
| GB9513683D0 (en) | 1995-09-06 |
| NO980021L (no) | 1998-03-02 |
| AU6311696A (en) | 1997-02-05 |
| NO980021D0 (no) | 1998-01-02 |
| CA2226258A1 (en) | 1997-01-23 |
| US6331425B1 (en) | 2001-12-18 |
| SK1398A3 (en) | 2000-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9900323A2 (hu) | Bakteriofág endoszialidáz aktivitással rendelkező rekombináns fehérje | |
| HUP9901640A3 (en) | Protein with phospholipase activity | |
| AU6255096A (en) | Pegylated modified proteins | |
| SG79882A1 (en) | Protein having tpo activity | |
| GB9616282D0 (en) | Enzyme activity enhancement | |
| GB9719879D0 (en) | Protein | |
| GB9703681D0 (en) | Protein complemention | |
| AU4030697A (en) | Proteins having telomerase activity | |
| GB9425582D0 (en) | Peptides having immunomodulatory activity | |
| EP1018551A4 (en) | MEGSINE PROTEIN | |
| HK1002961A1 (en) | Bacterial protein with xylanase activity. | |
| ZA96588B (en) | Anti-parasitic activity | |
| GB9715064D0 (en) | Protein expression | |
| AU7625598A (en) | Novel protein with chemokine activity | |
| HK1003896A1 (en) | Protein having tpo activity | |
| GB9519865D0 (en) | Protein | |
| GB9720784D0 (en) | Protein | |
| AU7600598A (en) | Human metaxin protein | |
| ZA951199B (en) | Protein having tpo activity | |
| GB9622436D0 (en) | Protein | |
| ZA976182B (en) | Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation. | |
| AU2476297A (en) | Polypeptide having beta-fructofuranosidase activity | |
| IL112632A0 (en) | Protein having tpo activity | |
| IL137028A0 (en) | Protein having tpo activity | |
| HK1004410A1 (en) | Protein having tpo activity. |